抑郁和焦虑可能降低类风湿关节炎与银屑病关节炎的缓解概率:NOR-DMARD 研究解读
基于前瞻性多中心 NOR-DMARD 队列,纳入 1326 例类风湿关节炎(RA)和 728 例银屑病关节炎(PsA)首次启用 TNF 抑制剂或甲氨蝶呤的患者。基线抑郁/焦虑(EuroQoL-5D-3L、SF-36 心理健康子量表≤56、SF-36 心理成分总分≤38)负向预测 RA 治疗 3 和 6 个月后多种复合缓解标准(p≤0.008),在 PsA 中部分预测(p 从 0.001 到 0.73)。基线抑郁/焦虑与随访时患者和评估者总体评估、压痛关节数及关节疼痛相关,但与肿胀关节数和急性期反应物无关。
要点
- 基线抑郁/焦虑负向预测 RA 治疗 3 和 6 个月后复合评分缓解(p≤0.008)。
- PsA 中抑郁/焦虑对缓解的预测作用仅部分成立(p 从 0.001 到 0.73)。
- 抑郁/焦虑与患者/评估者总体评估、压痛关节数和关节疼痛相关,与肿胀关节数和急性期反应物无关。
核心结论
- 抑郁和焦虑可能降低 RA 和 PsA 基于复合评分的关节缓解概率,个体化治疗目标决策时应予以考虑。
研究设计与样本
- 前瞻性观察性多中心 NOR-DMARD 研究,纳入 1326 例 RA 和 728 例 PsA 首次启用 TNF 抑制剂或甲氨蝶呤的患者。
- 采用预设 logistic 回归分析基线抑郁/焦虑对缓解的预测价值,预设多元线性回归分析其与缓解标准各组分的关系。
主要发现
- 基线抑郁/焦虑(EuroQoL-5D-3L、SF-36 心理健康子量表≤56、SF-36 心理成分总分≤38)负向预测 RA 治疗 3 和 6 个月后 DAS28<2.6、SDAI≤3.3、CDAI≤2.8、ACR/EULAR 布尔缓解及 DAPSA≤4 缓解(p≤0.008)。
- 在 PsA 中,基线抑郁/焦虑对上述缓解标准的预测作用仅部分成立(p 从 0.001 到 0.73)。
- 基线抑郁/焦虑与 RA 随访时患者和评估者总体评估、压痛关节数及关节疼痛相关,但与肿胀关节数和急性期反应物无关。
关键数值与推荐
- 抑郁/焦虑定义:EuroQoL-5D-3L、SF-36 心理健康子量表≤56、SF-36 心理成分总分≤38。
- RA 缓解标准:DAS28<2.6、SDAI≤3.3、CDAI≤2.8、ACR/EULAR 布尔缓解。
- PsA 缓解标准:DAPSA≤4。
- 评估时间点:治疗 3 和 6 个月。
临床怎么用
- 对 RA 和 PsA 患者制定治疗目标时,应评估并考虑抑郁/焦虑对实现复合评分缓解的潜在负面影响。
- 抑郁/焦虑主要影响患者报告和压痛相关指标,解读缓解评估时需注意其与肿胀关节数和急性期反应物的分离。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the predictive value of baseline depression/anxiety on the likelihood of achieving joint remission in rheumatoid arthritis (RA) and psoriatic arthritis (PsA) as well as the associations between baseline depression/anxiety and the components of the remission criteria at follow-up. METHODS: We included 1326 patients with RA and 728 patients with PsA from the prospective observational NOR-DMARD study starting first-time tumour necrosis factor inhibitors or methotrexate. The predictive value of depression/anxiety on remission was explored in prespecified logistic regression models and the associations between baseline depression/anxiety and the components of the remission criteria in prespecified multiple linear regression models. RESULTS: Baseline depression/anxiety according to EuroQoL-5D-3L, Short Form-36 (SF-36) Mental Health subscale ≤56 and SF-36 Mental Component Summary ≤38 negatively predicted 28-joint Disease Activity Score <2.6, Simplified Disease Activity Index ≤3.3, Clinical Disease Activity Index ≤2.8, ACR/EULAR Boolean and Disease Activity Index for Psoriatic Arthritis ≤4 remission after 3 and 6 months treatment in RA (p≤0.008) and partly in PsA (p from 0.001 to 0.73). Baseline depression/anxiety was associated with increased patient's and evaluator's global assessment, tender joint count and joint pain in RA at follow-up, but not with swollen joint count and acute phase reactants. CONCLUSION: Depression and anxiety may reduce likelihood of joint remission based on composite scores in RA and PsA and should be taken into account in individual patients when making a shared decision on a treatment target.
引用
- Michelsen B, Kristianslund EK, Sexton J, et al. Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study. Ann Rheum Dis. 2017. PMID: 28733473. doi:10.1136/annrheumdis-2017-211284
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。